NasdaqGM - Delayed Quote USD
Xenon Pharmaceuticals Inc. (XENE)
At close: 4:00 PM EDT
After hours: 4:18 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Operating Cash Flow
-153,552.00
-145,327.00
-98,430.00
-69,502.00
-48,124.00
--
Investing Cash Flow
-127,177.00
-117,170.00
-296,003.00
-246,770.00
-16,824.00
--
Financing Cash Flow
--
353,522.00
278,471.00
447,543.00
85,795.00
--
End Cash Position
137,345.00
148,643.00
57,242.00
175,688.00
45,009.00
--
Interest Paid Supplemental Data
--
--
--
--
339.00
917.00
Capital Expenditure
-2,980.00
-5,617.00
-2,894.00
-2,050.00
-2,637.00
--
Issuance of Capital Stock
--
353,487.00
277,766.00
447,283.00
102,456.00
--
Repayment of Debt
--
--
--
--
-16,743.00
--
Free Cash Flow
-156,532.00
-150,944.00
-101,324.00
-71,552.00
-50,761.00
--
12/31/2019 - 11/5/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
EWTX Edgewise Therapeutics, Inc.
34.42
-1.23%
CNTA Centessa Pharmaceuticals plc
15.46
-2.09%
KYMR Kymera Therapeutics, Inc.
48.37
+3.89%
PTGX Protagonist Therapeutics, Inc.
46.44
+1.04%
MRUS Merus N.V.
53.19
+3.08%
AGIO Agios Pharmaceuticals, Inc.
45.38
-0.61%
PRAX Praxis Precision Medicines, Inc.
72.25
-1.20%
RVMD Revolution Medicines, Inc.
47.13
-1.30%
AKRO Akero Therapeutics, Inc.
29.59
-4.24%
BHVN Biohaven Ltd.
52.65
+2.55%